Xufen Yu
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
Papers in
-
- Protein Degradation and Inhibitors 25
- Ubiquitin and proteasome pathways 15
- Histone Deacetylase Inhibitors Research 8
- Epigenetics and DNA Methylation 6
- Cancer-related gene regulation 4
-
- Multiple Myeloma Research and Treatments 8
- Co-authors
- Dianqing Sun (5 shared papers)Jian Jin (32 shared papers)Xiyan Lu (4 shared papers)Yudao Shen (10 shared papers)Jing Liu (6 shared papers)Jing Liu (11 shared papers)Gang Greg Wang (10 shared papers)Ling Cai (9 shared papers)
- Journals
- Journal of Medicinal Chemistry (10 papers)European Journal of Medicinal Chemistry (4 papers)Oncogene (3 papers)Journal of the American Chemical Society (2 papers)Science Advances (2 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
Xufen Yu
44 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 98
- Hematology 183
- Molecular Biology 1.1k
- Organic Chemistry 393
- Oncology 286
- Toxicology 19
Countries citing papers authored by Xufen Yu
This map shows the geographic impact of Xufen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufen Yu more than expected).
Fields of papers citing papers by Xufen Yu
This network shows the impact of papers produced by Xufen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufen Yu. The network helps show where Xufen Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xufen Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 184 | |
| 2 | 2020 | 144 | |
| 3 | 2022 | 119 | |
| 4 | 2021 | 91 | |
| 5 | 2020 | 69 | |
| 6 | 2019 | 57 | |
| 7 | 2009 | 48 | |
| 8 | 2022 | 42 | |
| 9 | 2021 | 40 | |
| 10 | 2023 | 35 | |
| 11 | 2022 | 32 | |
| 12 | 2022 | 31 | |
| 13 | 2011 | 31 | |
| 14 | 2011 | 31 | |
| 15 | 2022 | 30 | |
| 16 | 2021 | 28 | |
| 17 | 2019 | 28 | |
| 18 | 2019 | 27 | |
| 19 | 2022 | 26 | |
| 20 | 2022 | 26 |
About Xufen Yu
Xufen Yu is a scholar working on Molecular Biology, Hematology, Organic Chemistry, Oncology and Cellular and Molecular Neuroscience, having authored 45 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (25 papers), Ubiquitin and proteasome pathways (15 papers), Histone Deacetylase Inhibitors Research (8 papers), Multiple Myeloma Research and Treatments (8 papers), Epigenetics and DNA Methylation (6 papers), Catalytic C–H Functionalization Methods (4 papers), Cancer-related gene regulation (4 papers) and Catalytic Cross-Coupling Reactions (4 papers). The work is most often cited by research in Hematology (183 citations), Molecular Biology (1.1k citations), Organic Chemistry (393 citations), Oncology (286 citations) and Toxicology (19 citations). Xufen Yu has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Dianqing Sun, Jian Jin, Xiyan Lu, Yudao Shen, Jing Liu, Jing Liu, Gang Greg Wang, Ling Cai, Kwang‐Su Park and Xian Chen. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Oncogene, Journal of the American Chemical Society and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.